ERT Closes Acquisition of CareFusion Division

ERT (eResearchTechnology, Inc), a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries, has closed the acquisition of the Research Services Division of CareFusion Corporation (CRS). CRS manufactures diagnostic devices and provides respiratory diagnostics, cardiac safety and ePRO services. Dr Michael McKelvey, President and CEO of ERT, said: "The acquisition expands ERT’s capabilities, allows us to pursue new markets and reinforces our position as the leading service and technology provider enabling our customers to more efficiently collect, interpret and deliver clinical data during all
phases of drug development."

ERT paid $80.8 million in cash for CRS and the acquisition allows ERT to integrate all of the CRS offerings into its existing portfolio.